This Government Contract opportunity from Department Of Defense was posted on March 21, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Nuclear Medicine

Closed

HT941025N0028Federal

Submission Closed03/28/2025, 04:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The Defense Health Agency's Western Markets Contracting Division intends to award a sole source, firm fixed-price contract to GE Precision Healthcare LLC for maintenance services related to the GE FlashPad HD Detector 1717 at Naval Medical Center San Diego. This action is based on the determination that only GE Precision Healthcare LLC, as the original equipment manufacturer, can provide the necessary services, and no competitive solicitation exists for this requirement. The contract will cover a one-time service maintenance from January 25, 2025, through March 24, 2025, specifically for the GE FlashPad HD Detector located at the San Diego facility. Interested parties are invited to submit capability statements demonstrating their ability to perform the required services, with detailed management, technical, and cost information. These submissions must be concise, not exceeding eight pages, and are due by 10:00 AM Pacific Time on January 21, 2025, via email. The government will review all responses to determine whether to proceed with a sole source award or consider a competitive process. This notice emphasizes that it is not a solicitation and no solicitation document exists; responses are solely for the government's consideration to validate the sole source approach.

General Info

Agency

Department Of Defense → Defense Health Agency Hcd West

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

NV, 89191, USA

Set-Aside

NONE

Documents

SOW for Radiographic System Repair at MCAS Miramar

sow

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates

PhaseClosed

PostedJan 16

Combined Synopsis

Notice updatedJan 16

The notice description changed. The point of contact changed.

Notice updatedMar 21

Notice type changed from Combined Synopsis/Solicitation to Special Notice. Response deadline changed from Jan 21, 2025 to Mar 28, 2025. The notice title changed. NAICS code changed from 811210 to 325412. The notice description changed. The point of contact changed.

Response DeadlineMar 28

Deadline has passed

Submission Closed

03/28/2025, 04:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency Hcd West

Contacts2 people available

OfficeCAMP PENDLETON, CA, 92055, USA

Organization / AgencyDepartment Of Defense → Defense Health Agency Hcd West

Office AddressCAMP PENDLETON, CA, 92055, USA

Contacts

Griffin Bland

Brandi Roberts

Full Description

Notice of Intent to Sole Source HT941025N0028 THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division (WHOCD), intends to award a firm fixed price supply purchase to Cardinal Health for 99th Medical Group (MEDGRP) at Mike O'Callaghan Military Medical Center (MOMMC), Nellis Air Force Base (AFB), Nevada, in accordance with the Federal Acquisition Regulation (FAR) 13.901(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government's needs, to: CARDINAL HEALTH 7000 CARDINAL PL DUBLIN, OH 43017-1091 UEI: CWN9UGL3NCL9 CAGE: 3S229 The North American Industry Classification System (NAICS) code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing. The Product Service Code (PSC) is Q999 - Medical- Other. The requirement is to supply Radiopharmaceuticals for exams at MOFMC 99th MEDGRP. Location: Mike O'Callaghan Military Medical Center (MOMMC), Nellis AFB, NV 89191. Ordering Period: Base: 01 April 2025 - 31 March 2026 OY1: 01 April 2026 - 31 March 2027 OY2: 01 April 2027 - 31 March 2028 OY3: 01 April 2028 - 31 March 2029 OY4: 01 April 2029 - 31 March 2030 Based on market research, it has been determined that Cardinal Health is the only local Radiopharmaceutical company available to provide 24/7 supplies for Nuclear Medicine Departments that can meet the Government's requirement. Product ID # Description Quantity 101903 Venti-Scan IV Kit 24" 4 102314 Sealed Source Inventory 5 102330 I-123 Iobenguane Sulfate UD 1 102332 I-123 RC NaI Cap 12 102338 I-123 USP NaI 200 uCi Cap 28 102372 I-131 USP NaI TX Cap 30 102669 Potassium Iodide Tablet 14 102767 Sincalide Vial 40 102970 Tc-99m Macro Aggregated Albumin UD 9 102974 Tc-99m Mebrofenin UD 56 102977 Tc-99m Medronate UD 43 102980 Tc-99m Mertiatide UD 22 102983 Tc-99m NaTcO4 MD 1,100 102984 Tc-99m NaTcO4 UD mCi 16 102990 Tc-99m Pentetate UD 8 102991 Tc-99m Pyrophosphate UD 3 102994 Tc-99m Sestamibi UD 5 103003 Tc-99m Sulfur Colloid UD 30 103006 Tc-99m Tetrofosmin UD 777 103017 DC Accuracy 2 103020 DC Linearity 5 103027 Sealed Source Leak Test 10 103080 UltraTag Vial 13 103855 Tc-99m Filtered Sulfur Colloid (uCi) UD 84 105181 Area Wipe Collection and Analysis 57 107528 I-123 USP NAI 200uCi Cancellation Fee 1 198001 After Hours Callout 1 198002 After Hours Delivery Charge 1 199001 Weekday Delivery 1 245 199002 Weekday Delivery 2 100 199003 Weekday Delivery 3 14 199004 Weekday Delivery 4 1 199006 Weekend Delivery 1 2 TOTAL: 2,739 Cardinal Health is the only source that can provide Nuclear Medicine supplies that can meet the Government's minimum requirements to provide the requested 24/7 supplies for Nuclear Medicine Departments mentioned above at MOFMC 99th MEDGRP at Nellis AFB, NV. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the above requirement. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Griffin Bland at Griffin.Bland.civ@health.mil and Brandi Roberts at Brandi.m.Roberts5@health.mil. The closing date for challenges is no later than 09:00 Pacific Time, Monday, 20 MAR 2025. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.